期刊文献+

布拉氏酵母菌联合三联疗法治疗幽门螺杆菌消化性溃疡的临床疗效观察 被引量:17

Clinical observation on effect of Saccharomyces boularidii combined triple treatment in Helicobacter pylori associated with peptic ulcer
下载PDF
导出
摘要 目的探讨布拉氏酵母菌联合三联疗法治疗幽门螺杆菌阳性(Hp阳性)消化性溃疡的临床疗效。方法将我院2011年12月~2012年2月收治的120例HP阳性消化性溃疡患者分为观察组和对照组,对照组采用西药三联疗法治疗,观察组在对照组的基础上采用布拉氏酵母菌治疗,比较两组患者的疗效。结果观察组的Hp根除率为90.0%显著高于对照组的80.0%,差异有统计学意义(P<0.05)。观察组治疗后的症状积分显著低于对照组,溃疡愈合率显著高于对照组,差异有统计学意义(P<0.05)。观察组的腹泻发生率显著低于对照组,差异有统计学意义(P<0.05)。结论布拉氏酵母菌能够提高三联疗法治疗消化性溃疡的Hp根除率,并降低三联疗法引发的腹泻发生率,值得临床推广。
出处 《湖南中医药大学学报》 CAS 2013年第4期18-19,共2页 Journal of Hunan University of Chinese Medicine
关键词 布拉氏酵母菌 三联疗法 HP阳性 消化性溃疡 Saccharomyces boularidii Triple treatment Hp(+) Peptic ulcer Efficacy
  • 相关文献

参考文献6

二级参考文献55

  • 1张信,周和,孙宏慧,区都,田伟.雷贝拉唑与奥美拉唑三联疗法治疗幽门螺杆菌阳性消化性溃疡疗效比较——附40例分析[J].新医学,2004,35(7):401-403. 被引量:46
  • 2陈元鸿,王婉梅,王皓,李红艳.埃索美拉唑三联与奥美拉唑三联疗法治疗Hp阳性十二指肠溃疡对比研究[J].第一军医大学学报,2005,25(8):1045-1047. 被引量:82
  • 3Marshall BJ,Warren JR.Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration.Lancet,1984,1:1811-1315.
  • 4NIH Consensus Conference.Helicobacter pylori in peptic ulcer disease.NIH Consensus Development Panel on Helicobacter pylori in Peptic Ulcer Disease.JAMA,1994,272:65-69.
  • 5Malfertheiner P,Megraud F,O'Morain C,et al.Current concepts in the management of Helieobacter pylori infection:the Maastricht Ill Consensus Report,Gut,2007,56:772-781.
  • 6Lain SK,Talley NJ.Report of the 1997 Asia Pacific Consensus Conference on the management of Helicobacter pylori infection.J Gastroenterol Hepatol,1998,13:1-12.
  • 7Asaka M,Satoh K,Sugano K,et al.Guidelines in the management of Helicobacter pylori infection in Japan.Helicobaeter,2001,6:177-186.
  • 8Miwa H,Sakaki N,Sugano K,et al.Recurrent peptic ulcers in patients following successful Helicobaeter pylori eradications a multicenter study of 4940 patients.Helicobacter,2004,9:9-16.
  • 9Lee JH,Kim N,Chung JI,et al.Long-term follow up of Helicobacter pylori IgG serology after eradication and reinfection rate of H.pylori in South Korea.Helicobaeter,2008,13:288-294.
  • 10Niv Y,Hazazi R,Waked A,et al.Helicobacter pylori recurrence and infection rate in Israeli adults.Dig Dis Sci,2008,53:1211-1214.

共引文献76

同被引文献124

  • 1房静远,刘文忠,李兆申,杜亦奇,纪小龙,戈之铮,李延青,姒健敏,吕农华,吴开春,陈萦,萧树东.中国慢性胃炎共识意见(2012年,上海)[J].中国医学前沿杂志(电子版),2013,5(7):44-55. 被引量:153
  • 2魏东卉,杨楠,王志,王朝周,王芬娟,郭晨雯.青岛地区3种根除幽门螺杆菌治疗方法的临床观察比较[J].军事医学科学院院刊,2007,31(2):152-154. 被引量:2
  • 3储波,蒋丽蓉,周莎,徐亚珍,殷敏智.幽门螺杆菌菌株类型与儿童上消化道疾病的关系[J].中国当代儿科杂志,2007,9(3):201-204. 被引量:7
  • 4胡亚美 江载芳.诸福棠实用儿科学[M].北京:人民卫生出版社,2002.1294.
  • 5成虹,胡伏莲,谢勇,胡品津,王吉耀,吕农华,张建中,张桂英,周曾芬,吴克利,张玲霞,彭孝伟,戴宁,唐国都,姜葵,李岩,侯晓华,白文元,王明春,叶红军,刘玉兰,许乐.中国幽门螺杆菌耐药状况以及耐药对治疗的影响—全国多中心临床研究[J].胃肠病学,2007,12(9):525-530. 被引量:518
  • 6Abbas Z, Yakoob J, Jafri W, et al. Cytokine and clinical response to Saccharomyces boulardii therapy in diarrhea-dominant irritable bowel syndrome: a randomized trial [ J ]. Gastroenterol Hepatol, 2014, 26(6): 630-639.
  • 7Maioli TU, de Melo Silva B, Dias MN, et al. Pretreatment with Sac- charomyces boulardii does not prevent the experimental mucositis in Swiss mice[J]. Negat Results Biomed, 2014, : !11(13) : 611-631.
  • 8Szajewska H, Guarino A, Hojsak I, et al. Use of probiotics for management of acute gastroenteritis: i a position paper by the ES- PGHAN Working Group for Probiotics and Prebiotics [ J ]. Pediatr Gastroenterol Nutr, 2014, 58(4) : 531-539.
  • 9Justino PF, Melo LF, Nogueira AF, et al, Treatment with Saccha- romyces boulardii reduces the inflammation and dysfunction of the gastrointestinal tract in 5-fluorouraciI-induced intestinal mucositis in mice[J].BrJNutr, 2014, 111(9): 1611-21.
  • 10Capuano F, Mtilleder M, Kok R, et al. Cytosine DNA methylation is found in Drosophila melanogaster but absent in Saccharomyces cerevisiae, Schizosaccharomyces pombe, and other yeast species [J]. Anal Chem, 2014, 86(8) : 3697-3702.

引证文献17

二级引证文献87

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部